Why not use the HbA1c as a criterion of dysglycemia in the new definition of the metabolic syndrome? Impact of the new criteria in the prevalence of the metabolic syndrome in a Mediterranean urban population from Southern Europe (IMAP study. Multidisciplinary intervention in primary care)

Abstract We analysed the prevalence of metabolic syndrome (MS) of the new diagnostic criteria and the HbA1c to diagnose dysglycemia. We studied 2006 adults without cardiovascular disease or diabetes. The use of the new criteria and the HbA1c resulted in an increase in the population prevalence of MS...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes research and clinical practice 2011-08, Vol.93 (2), p.e57-e60
Main Authors: Bernal-Lopez, M. Rosa, Villalobos-Sanchez, Aurora, Mancera-Romero, Jose, Jansen-Chaparro, Sergio, Baca-Osorio, Antonio J, Lopez-Carmona, Maria Dolores, Tinahones, Francisco J, Gomez-Huelgas, Ricardo
Format: Article
Language:English
Subjects:
Adult
Cardiovascular Diseases - epidemiology
Diabetes Mellitus - epidemiology
Dysglicemia
Endocrinology & Metabolism
Europe - epidemiology
Female
Glicated hemoglobin (HbA1c)
Glycated Hemoglobin A - analysis
Humans
Male
Mediterranean Region - epidemiology
Metabolic syndrome
Metabolic Syndrome - diagnosis
Metabolic Syndrome - epidemiology
Middle Aged
New Criteria
Prevalence
Urban Population
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract We analysed the prevalence of metabolic syndrome (MS) of the new diagnostic criteria and the HbA1c to diagnose dysglycemia. We studied 2006 adults without cardiovascular disease or diabetes. The use of the new criteria and the HbA1c resulted in an increase in the population prevalence of MS.
ISSN:0168-8227
1872-8227
DOI:10.1016/j.diabres.2011.02.024